Featured Insight

Global Financial and Economic Crime Outlook 2025

April 10, 2025

Search Insights

Latest Insights

Article  |  March 31, 2025

The Future of eDiscovery: Generative AI’s Impact

Generative AI is transforming eDiscovery, reshaping legal document review with greater efficiency and scalability. But as with predictive coding, technology alone is not enough. Human expertise remains essential to ensure accuracy, mitigate bias, and uphold ethical standards.

Read More
News  |  March 26, 2025

AI Adoption Surges in the Legal Industry: Key Findings from the 2025 Secretariat and ACEDS Global Artificial Intelligence Report

The 2025 Artificial Intelligence Report, conducted by Secretariat in collaboration with ACEDS, has revealed groundbreaking insights into the rapidly evolving role of artificial intelligence (AI) in the legal industry. With a focus on Generative AI (GenAI) and its increasing integration into legal workflows, the survey provides essential data for organizations navigating the future of legal practice and technology.  Now in its third year, the report’s research and analysis was once again led by legal AI expert Richard Finkelman in collaboration with ACEDS. This year also marks the first partnership with Secretariat to sponsor this comprehensive study.

Read More
News  |  March 26, 2025

Secretariat and ACEDS 2025 Artificial Intelligence Report

We’re excited to announce the launch of our latest Artificial Intelligence (AI) global report in collaboration with ACEDS, providing a critical snapshot of industry sentiment, adoption trends, and the evolving role of AI in legal practice.

Read More

See All Insights

Events

See All Events
featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Read More
View All Engagements

Media Contact

If you would like to schedule an interview or would like more information about our firm and individual experts, please contact:

Nathan Jenks
Director of Marketing & Communications
Email: njenks@secretariat-intl.com